Home | NRI | Business Associates | Knowledge Bank | Careers | Back Office | Contact Us
 

Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
 
 
Profit and Loss
ERIS Lifesciences Ltd
    Industry   : Pharmaceuticals - Indian - Formulations  Chairman  : Amit Indubhushan Bakshi
    Home        : Indian Private  Book Value: 203.3941378
    BSE Code  : 540596  Market Cap: 22667.85
    NSE Code  : ERIS  P / E              : 80.43 

Change Company :
(Rs in Cr.)
Profit and Loss
ParticularsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Sales Turnover & Other Income 1739.541563.111357.631244.721118.83
Excise Duty0.000.000.000.000.00
Total Income1783.081576.261349.131242.231131.40
Raw Materials 542.79293.31227.88197.16211.08
Stock Adjustments 43.5413.15-8.50-2.4912.57
Other Manufacturing Expenses 22.3516.8011.507.477.16
Power & Fuel Cost4.104.464.414.013.89
Employee Cost 361.92331.67252.52220.11207.02
Selling and Administration Expenses 223.80319.27242.67215.51181.66
Miscellaneous Expenses 106.06122.1087.7884.9393.13
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax522.06488.65522.38513.05427.48
Interest & Financial Charges 220.2457.4220.813.050.94
Profit before Depreciation & Tax301.82431.23501.57510.00426.54
Depreciation181.77102.3964.6651.4637.64
Profit Before Tax120.05328.84436.91458.54388.90
Tax42.6629.1238.9041.3538.29
Profit After Tax77.39299.72398.01417.19350.61
Adjustment below Net Profit -2.84-2.76-0.15-1.01-1.28
P & L Balance brought forward2487.172190.211892.281557.741283.09
Appropriations 100.060.0099.9381.6574.68
P & L Bal. carried down2461.662487.172190.211892.281557.74
Equity Dividend100.060.0099.9381.6574.68
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)735.000.00735.00601.00550.00
Earning Per Share (Rs.)5.6822.0429.2730.6925.82
Book Value184.65185.59163.39141.11116.03
Extraordinary Items 1.352.795.17-1.722.33
Top
BSE Disclaimer     |     Disclaimer     |     Privacy Statement     |     Terms of Use     |     Feedback     |    Sitemap     |    Downloads    |     Client Bank Details
Useful Links   | Risk Disclosure   | Rules and Regulations   |   Investor Charter / Complaints   |   Smart ODR   |   Scores   |   Attention Investors   | Audit Compliance Report   | RA – Annual Compliance Audit Report 2024-25   |

SEBI Saa₹thi Mobile App/SEBI Investor Website  

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved Developed & Maintained By C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by Capital Market Charts are powered by TradingView